A biotechnology firm focused on developing complex generic drugs and immune‑mediated disease therapies, with expertise in characterizing biologic and polysaccharide compounds. The company built its reputation through work on biosimilars and follow‑on biologics, including a generic version of the ant...
No congressional trades have been disclosed for Momenta Pharmaceuticals, Inc. (MOPH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.